What question did this study set out to answer?

To evaluate the efficacy of the pro-resolving mediator resolvin D5 (RvD5), alone and alongside antibiotics, in limiting lung injury and promoting host defense during severe pneumococcal pneumonia.

August 14, 2026Clinical ScienceOpen Access

Resolvin D5 limits inflammatory lung injury and enhances antibacterial host defense in severe pneumococcal pneumonia

View Full Paper

Ask AI

Bookmark

To evaluate the efficacy of the pro-resolving mediator resolvin D5 (RvD5), alone and alongside antibiotics, in limiting lung injury and promoting host defense during severe pneumococcal pneumonia.
Treated a mouse model of severe Streptococcus pneumoniae infection with exogenous RvD5 alone at infection onset or post-infection in combination with the antibiotic ceftriaxone.
Assessed bacterial burden, neutrophil accumulation and activation markers, and alveolar barrier integrity in lung tissue and bronchoalveolar lavage (BAL) fluid.
Performed in vitro assays using human neutrophils to evaluate bacterial phagocytic uptake, intracellular killing, and leukotriene B4 (LTB4)-mediated calcium mobilization.
Early RvD5 administration reduced neutrophil infiltration and activation markers, lowered BAL total protein levels, and enhanced bacterial clearance in infected mice.
Post-infection RvD5 combined with ceftriaxone significantly decreased lung neutrophil counts and improved alveolar barrier integrity compared with antibiotic treatment alone.
In vitro human neutrophil assays showed that RvD5 boosted bacterial phagocytosis and killing while dampening secondary calcium mobilization triggered by LTB4.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Preclinical study demonstrates that resolvin D5 reduces lung damage and enhances bacterial clearance in pneumococcal pneumonia, suggesting its potential as an antibiotic adjunct.

Cite This Study

Gong et al. (2026) studied this question.

synapsesocial.com/papers/6a7ec78db70b84ec8b913f09 https://doi.org/10.1042/cs20261424

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study demonstrates that resolvin D5 reduces lung damage and enhances bacterial clearance in pneumococcal pneumonia, suggesting its potential as an antibiotic adjunct.

Resolvin D5 limits inflammatory lung injury and enhances antibacterial host defense in severe pneumococcal pneumonia

Key Points

Discussion

Implication

Cite This Study

Resolvin D5 limits inflammatory lung injury and enhances antibacterial host defense in severe pneumococcal pneumonia

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider